FDA Approved: TACROLIMUS — Supplemental Application (E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC)

View source ↗

Summary

The FDA approved a supplemental application for tacrolimus from E. Fougera & Co., a division of Fougera Pharmaceuticals, LLC. The action pertains to the approva…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis
• Organ Transplant Rejection Prophylaxis

Drugs mentioned

• Tacrolimus (Tacrolimus)

Snippet

SUPPL AP for TACROLIMUS (TACROLIMUS)